Evidence map›Paper›PMID 24876540›Full record

ArticleJournal of diabetes science and technology2014

Average Daily Risk Range (ADRR) in Young Children With Type 1 Diabetes.

Maureen Monaghan, Tamiko B Younge, Robert McCarter, Fran R Cogen, Randi Streisand

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Protective Factors in Young Children With Type 1 Diabetes.Journal of pediatric psychology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maureen MonaghanChildren's National Medical Center, Washington, DC, USA George Washington University School of Medicine, Washington, DC, USA mmonagha@childrensnational.org.
Tamiko B YoungeChildren's National Medical Center, Washington, DC, USA.
Robert McCarterChildren's National Medical Center, Washington, DC, USA George Washington University School of Medicine, Washington, DC, USA.
Fran R CogenChildren's National Medical Center, Washington, DC, USA George Washington University School of Medicine, Washington, DC, USA.
Randi StreisandChildren's National Medical Center, Washington, DC, USA George Washington University School of Medicine, Washington, DC, USA.

Funding

Parenting & Control Among Young Children with T1 DiabetesR01DK080102 · NIDDK · CHILDREN'S RESEARCH INSTITUTE · PI STREISAND, RANDI · 2008 to 2012
$3.0M
Clinical and Translational Science Institute at Children's NationalKL2TR000076 · NCATS · CHILDREN'S RESEARCH INSTITUTE · PI GUAY-WOODFORD, LISA MARIE · 2012 to 2014
$756k
NCATS NIH HHS KL2 TR000076NIDDK NIH HHS R01 DK080102
6 · The paper itself

Abstract

objectiveThe objective was to examine the utility of the average daily risk range (ADRR) in young children with type 1 diabetes.

methodsSelf-monitored blood glucose (BG) data and A1c values were collected from 134 children (ages 2-6). Other measures of BG variability and diabetes care were calculated using self-monitored BG data. ADRR, A1c, and other glycemic indices were compared to assess their distinctiveness and utility as measures of BG variability and glycemic control.

resultsOf young children's ADRR values, 72% were in the "high-risk" range using adult guidelines. ADRR and A1c were highly correlated with indicators of hyperglycemia but only weakly correlated with measures of hypoglycemia. ADRR was moderately correlated with minimum BG value in the past 30 days but not percentage of BG values below 70 mg/dL. A1c was not correlated with either measure of hypoglycemia.

conclusionsADRR values confirm the high degree of BG variability present in young children with type 1 diabetes, particularly as compared with adults. New ADRR risk guidelines are needed for pediatric patients. ADRR and A1c are adequate indicators of hyperglycemia in young children. However, both ADRR and A1c failed to effectively capture hypoglycemia risk in this sample, and neither ADRR nor A1c can take the place of review of raw BG data to evaluate BG variability in young children.

Indexed as

average daily risk rangeblood glucoseglycemic variabilityhemoglobin A1chypoglycemia risktype 1 diabetesyoung children

Identifiers

PMID24876540
PMCPMC4454111

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.